CHICAGO TRUST Co NA decreased its holdings in Cigna Corp (NYSE:CI) by 4.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,789 shares of the health services provider’s stock after selling 76 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Cigna were worth $287,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of CI. CI Investments Inc. increased its stake in shares of Cigna by 4.7% during the third quarter. CI Investments Inc. now owns 835,400 shares of the health services provider’s stock valued at $173,972,000 after purchasing an additional 37,550 shares in the last quarter. Highland Capital Management LP bought a new position in shares of Cigna during the third quarter valued at approximately $1,041,000. Capital Research Global Investors purchased a new stake in shares of Cigna during the third quarter valued at approximately $682,210,000. Capital World Investors grew its holdings in shares of Cigna by 172.7% during the third quarter. Capital World Investors now owns 5,464,526 shares of the health services provider’s stock valued at $1,137,988,000 after buying an additional 3,460,726 shares during the last quarter. Finally, Bell Rock Capital LLC purchased a new stake in shares of Cigna during the third quarter valued at approximately $217,000. 88.31% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts have recently commented on the stock. Morgan Stanley assumed coverage on shares of Cigna in a report on Thursday, December 13th. They set an “overweight” rating and a $304.00 price target on the stock. Zacks Investment Research cut shares of Cigna from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 20th. Stephens assumed coverage on shares of Cigna in a report on Monday, January 14th. They set an “overweight” rating and a $251.00 price target on the stock. Goldman Sachs Group reiterated a “buy” rating on shares of Cigna in a report on Saturday, February 2nd. Finally, ValuEngine cut shares of Cigna from a “hold” rating to a “sell” rating in a report on Friday, December 28th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and thirteen have issued a buy rating to the company. Cigna currently has an average rating of “Buy” and an average target price of $231.28.

In other news, Director John Partridge sold 1,000 shares of Cigna stock in a transaction on Thursday, February 7th. The shares were sold at an average price of $184.43, for a total transaction of $184,430.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michael W. Triplett sold 9,148 shares of Cigna stock in a transaction on Monday, February 11th. The stock was sold at an average price of $181.01, for a total transaction of $1,655,879.48. The disclosure for this sale can be found here. Insiders sold 10,420 shares of company stock worth $1,886,122 in the last 90 days. 0.80% of the stock is currently owned by corporate insiders.

CI stock traded down $1.31 on Wednesday, hitting $167.82. The company had a trading volume of 62,314 shares, compared to its average volume of 2,776,167. Cigna Corp has a 12-month low of $158.00 and a 12-month high of $226.60. The company has a current ratio of 0.42, a quick ratio of 0.42 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $64.28 billion, a P/E ratio of 11.80, a P/E/G ratio of 0.82 and a beta of 0.71.

Cigna (NYSE:CI) last issued its earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The company had revenue of $13.75 billion during the quarter, compared to analysts’ expectations of $11.38 billion. During the same quarter in the prior year, the business posted $1.94 EPS. The company’s revenue for the quarter was up 29.3% compared to the same quarter last year. As a group, equities analysts predict that Cigna Corp will post 16.41 earnings per share for the current year.

The business also recently announced a special dividend, which will be paid on Wednesday, April 10th. Investors of record on Monday, March 11th will be issued a $0.04 dividend. The ex-dividend date is Friday, March 8th. Cigna’s dividend payout ratio is currently 0.28%.

WARNING: This story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.watchlistnews.com/chicago-trust-co-na-sells-76-shares-of-cigna-corp-ci/2953357.html.

About Cigna

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Story: How does a 12b-1 fee affect fund performance?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.